The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal

Lauren C. Kruse, Kari Buck

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Sedative-hypnotic drugs including alcohol, benzodiazepines, and barbiturates, are widely used and abused for their euphoric and sedative properties. Sedative-hypnotic abuse and addiction is a complex, heterogeneous disorder, with biological (genetic) factors strongly influencing risk for dependence. Physiological dependence and associated withdrawal are thought to be a powerful motivational force that perpetuates sedative-hypnotic use/abuse, and enhances vulnerability to relapse. Recently, the substantia nigra pars reticulata (SNr) has been identified as crucially involved in sedative-hypnotic withdrawal symptoms (e.g., convulsions). The Mpdz gene has been implicated in sedative-hypnotic physiological dependence and associated withdrawal episodes in mice, with Mpdz expression within the caudolateral subregion of the SNr crucially involved.

Original languageEnglish (US)
Title of host publicationGeneral Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions
PublisherElsevier Inc.
Pages345-355
Number of pages11
Volume3
ISBN (Electronic)9780128006771
ISBN (Print)9780128006344
DOIs
StatePublished - May 13 2016

Fingerprint

Hypnotics and Sedatives
Substance Withdrawal Syndrome
Barbiturates
Biological Factors
Benzodiazepines
Pars Reticulata
Seizures
Alcohols
Recurrence
Pharmaceutical Preparations
Genes

Keywords

  • Alcohol
  • Barbiturate
  • Benzodiazepine
  • Dependence
  • GABA
  • Genetic
  • Mpdz
  • MUPP1
  • Sedative
  • Substantia nigra
  • Withdrawal

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kruse, L. C., & Buck, K. (2016). The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions (Vol. 3, pp. 345-355). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800634-4.00034-2

The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal. / Kruse, Lauren C.; Buck, Kari.

General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier Inc., 2016. p. 345-355.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kruse, LC & Buck, K 2016, The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal. in General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. vol. 3, Elsevier Inc., pp. 345-355. https://doi.org/10.1016/B978-0-12-800634-4.00034-2
Kruse LC, Buck K. The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3. Elsevier Inc. 2016. p. 345-355 https://doi.org/10.1016/B978-0-12-800634-4.00034-2
Kruse, Lauren C. ; Buck, Kari. / The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal. General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier Inc., 2016. pp. 345-355
@inbook{a4579e80c3ba47cbad9dee00c324c144,
title = "The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal",
abstract = "Sedative-hypnotic drugs including alcohol, benzodiazepines, and barbiturates, are widely used and abused for their euphoric and sedative properties. Sedative-hypnotic abuse and addiction is a complex, heterogeneous disorder, with biological (genetic) factors strongly influencing risk for dependence. Physiological dependence and associated withdrawal are thought to be a powerful motivational force that perpetuates sedative-hypnotic use/abuse, and enhances vulnerability to relapse. Recently, the substantia nigra pars reticulata (SNr) has been identified as crucially involved in sedative-hypnotic withdrawal symptoms (e.g., convulsions). The Mpdz gene has been implicated in sedative-hypnotic physiological dependence and associated withdrawal episodes in mice, with Mpdz expression within the caudolateral subregion of the SNr crucially involved.",
keywords = "Alcohol, Barbiturate, Benzodiazepine, Dependence, GABA, Genetic, Mpdz, MUPP1, Sedative, Substantia nigra, Withdrawal",
author = "Kruse, {Lauren C.} and Kari Buck",
year = "2016",
month = "5",
day = "13",
doi = "10.1016/B978-0-12-800634-4.00034-2",
language = "English (US)",
isbn = "9780128006344",
volume = "3",
pages = "345--355",
booktitle = "General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal

AU - Kruse, Lauren C.

AU - Buck, Kari

PY - 2016/5/13

Y1 - 2016/5/13

N2 - Sedative-hypnotic drugs including alcohol, benzodiazepines, and barbiturates, are widely used and abused for their euphoric and sedative properties. Sedative-hypnotic abuse and addiction is a complex, heterogeneous disorder, with biological (genetic) factors strongly influencing risk for dependence. Physiological dependence and associated withdrawal are thought to be a powerful motivational force that perpetuates sedative-hypnotic use/abuse, and enhances vulnerability to relapse. Recently, the substantia nigra pars reticulata (SNr) has been identified as crucially involved in sedative-hypnotic withdrawal symptoms (e.g., convulsions). The Mpdz gene has been implicated in sedative-hypnotic physiological dependence and associated withdrawal episodes in mice, with Mpdz expression within the caudolateral subregion of the SNr crucially involved.

AB - Sedative-hypnotic drugs including alcohol, benzodiazepines, and barbiturates, are widely used and abused for their euphoric and sedative properties. Sedative-hypnotic abuse and addiction is a complex, heterogeneous disorder, with biological (genetic) factors strongly influencing risk for dependence. Physiological dependence and associated withdrawal are thought to be a powerful motivational force that perpetuates sedative-hypnotic use/abuse, and enhances vulnerability to relapse. Recently, the substantia nigra pars reticulata (SNr) has been identified as crucially involved in sedative-hypnotic withdrawal symptoms (e.g., convulsions). The Mpdz gene has been implicated in sedative-hypnotic physiological dependence and associated withdrawal episodes in mice, with Mpdz expression within the caudolateral subregion of the SNr crucially involved.

KW - Alcohol

KW - Barbiturate

KW - Benzodiazepine

KW - Dependence

KW - GABA

KW - Genetic

KW - Mpdz

KW - MUPP1

KW - Sedative

KW - Substantia nigra

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=84978343620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978343620&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800634-4.00034-2

DO - 10.1016/B978-0-12-800634-4.00034-2

M3 - Chapter

SN - 9780128006344

VL - 3

SP - 345

EP - 355

BT - General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions

PB - Elsevier Inc.

ER -